Avalon.ai, a NYC-based AI-based enterprise software and data analytics company that supports business, government, educational and healthcare silos, closed a $1.5m seed funding round.
The round was led by pharmaceutical company Pacira BioSciences, along with additional investments across the health, research and bioscience industries. As part of the agreement Pacira Chief Customer Officer Dennis McLoughlin will join the Avalon.ai board.
The capital will be used to further expand the reach of Avalon.ai in both the U.S. and Europe.
Led by CEO Christopher Malter, Avalon.ai is an AI company dedicated to developing real time healthcare enterprise solutions, connecting customers with end users through smart technology. The company, which has formed partnerships with Oxford University, Fintel Labs, Code Skools and Pacira BioSciences, can help measure metrics as it relates to COVID-19 and can provide data and analysis for other world challenges such as the ongoing fight against the opioid epidemic.